Terms: = Breast cancer AND SEPT9, PNUTL4, 10801, ENSG00000184640, MSF1, KIAA0991, AF17q25, MSF, SeptD1, SINT1 AND Prognosis
4 results:
1. Methylated sept9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma.
Saeki I; Suehiro Y; Yamauchi Y; Hoshida T; Tanabe N; Oono T; Kawamoto D; Nishimura T; Matsumoto T; Ishikawa T; Shimokawa M; Tamori A; Kawada N; Tamai Y; Iwasa M; Nakagawa H; Nagano H; Takami T; Yamasaki T
Hepatol Int; 2023 Oct; 17(5):1289-1299. PubMed ID: 37186217
[TBL] [Abstract] [Full Text] [Related]
2. Migration Stimulating Factor (msf): Its Role in the Tumour Microenvironment.
Schor AM; Woolston AM; Kankova K; Harada K; Aljorani LE; Perrier S; Felts PA; Keatch RP; Schor SL
Adv Exp Med Biol; 2021; 1329():351-397. PubMed ID: 34664248
[TBL] [Abstract] [Full Text] [Related]
3. prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC breast cancer Cooperative Group and the Danish breast cancer Cooperative Group.
van Tienhoven G; Voogd AC; Peterse JL; Nielsen M; Andersen KW; Mignolet F; Sylvester R; Fentiman IS; van der Schueren E; van Zijl K; Blichert-Toft M; Bartelink H; van Dongen JA
Eur J Cancer; 1999 Jan; 35(1):32-8. PubMed ID: 10211085
[TBL] [Abstract] [Full Text] [Related]
4. breast cancer: a study into the value of a historical group as comparative material for new methods of treatment.
Hooning MJ; van Dongen JA; Hart AA; Peterse JL; Bruggink ED; Went G
Eur J Surg Oncol; 1992 Feb; 18(1):16-22. PubMed ID: 1737588
[TBL] [Abstract] [Full Text] [Related]
